COVID-19, microangiopathy, hemostatic activation, and complement

J Clin Invest. 2020 Aug 3;130(8):3950-3953. doi: 10.1172/JCI140183.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Betacoronavirus
  • COVID-19
  • Complement Activation
  • Complement System Proteins / immunology*
  • Coronavirus Infections / complications*
  • Coronavirus Infections / immunology
  • Hemostasis
  • Humans
  • Necrosis
  • Pandemics
  • Phenotype
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / immunology
  • Respiratory Distress Syndrome
  • SARS-CoV-2
  • Thrombosis
  • Thrombotic Microangiopathies / complications*

Substances

  • Complement System Proteins